Haemonetics Corporation HAE
NYSE
| 09/26/2026 | 06/27/2026 | 03/28/2026 | 12/27/2025 | 09/27/2025 | |
|---|---|---|---|---|---|
| Net Income | 103.91M | 96.29M | 97.31M | 175.44M | 168.19M |
| Total Depreciation and Amortization | 103.48M | 103.97M | 105.62M | 105.91M | 107.55M |
| Total Amortization of Deferred Charges | 6.10M | 6.10M | 6.10M | 6.70M | 6.70M |
| Total Other Non-Cash Items | 107.63M | 109.97M | 107.85M | 28.68M | 31.61M |
| Change in Net Operating Assets | 23.82M | 11.83M | -23.65M | 22.12M | -25.01M |
| Cash from Operations | 344.93M | 328.15M | 293.22M | 338.84M | 289.04M |
| Capital Expenditure | -46.69M | -36.93M | -32.78M | -30.76M | -32.96M |
| Sale of Property, Plant, and Equipment | 1.77M | 1.32M | 1.38M | 3.30M | 3.12M |
| Cash Acquisitions | -60.18M | -60.18M | -60.18M | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | 43.29M | 43.29M |
| Other Investing Activities | -57.50M | -72.98M | -87.96M | -90.72M | -76.25M |
| Cash from Investing | -162.60M | -168.78M | -179.55M | -74.89M | -62.80M |
| Total Debt Issued | 300.00M | 300.00M | 300.00M | 0.00 | 0.00 |
| Total Debt Repaid | -406.25M | -356.25M | -306.25M | -6.25M | -6.25M |
| Issuance of Common Stock | 9.39M | 7.50M | 7.89M | 7.91M | 7.68M |
| Repurchase of Common Stock | -104.09M | -178.72M | -180.00M | -229.96M | -230.24M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -17.65M | -80.00K | -102.00K | -116.00K | -251.00K |
| Cash from Financing | -218.61M | -227.55M | -178.46M | -228.41M | -229.06M |
| Foreign Exchange rate Adjustments | 563.00K | -1.34M | 3.46M | 6.99M | -33.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -35.71M | -69.51M | -61.32M | 42.52M | -2.86M |